Humm Kombucha Launches Its First-Ever, Three-Flavor Variety Pack in Costco

June 26, 2018, 7:16 am

≫ Next: Macron and Pope talk poverty, migration and Europe in long meeting

≪ Previous: Data443 Partners with Leading Value-Added Global Distributor Headtechnology Group

The world’s most drinkable kombucha is now available in 35+ Southern California locations

LOS ANGELES (PRWEB) June 26, 2018

Humm Kombucha, the world’s most drinkable kombucha, is launching its first-ever variety pack in exclusive retail partnership with 35+ Costco warehouses in Southern California. The new case will feature three of Humm Kombucha’s fan-favorite flavors: Pomegranate Lemonade, Coconut Lime and Hopped Grapefruit. The variety pack contains 12 bottles (4 of each flavor) at $26.99 MSRP.

Humm is authentic kombucha, not from concentrate, with certified USDA organic and all natural ingredients. Each bottle is verified non-alcoholic, GMO Free, contains antioxidants and over 2 billion probiotics. All three flavors feature fermented tea and unique flavor pairings, providing a delicious option for hardcore wellness shoppers to thirsty kids. The brand’s additional flavors are sold at major retailers nationwide.

“We have always believed that kombucha should be for everyone,” said Jamie Danek, CEO and Co-founder, Humm Kombucha. “Partnering with Costco is a great opportunity for Humm to connect with wellness shoppers and families that are committed to purchasing high quality kombucha. We believe healthy, organic foods should be accessible to everyone.”

To celebrate the launch, Humm is offering a giveaway on its social channels throughout the summer. For more info, visit: https://hummkombucha.com/find-humm/

ABOUT HUMM KOMBUCHA:
Humm is the world’s most drinkable kombucha and a fan favorite amongst families, athletes and wellness seekers. Founded in 2009 by kombucha enthusiasts Jamie Danek and Michelle Mitchell, the company is one the largest, fastest growing, and beloved kombucha brands. From the company’s early days brewing in the founders’ kitchen through its movement to a full-scale brewery, Humm Kombucha has remained focused on taste, accessibility, and overall wellness because health and happiness go hand-in-hand. Humm can be found in grocery stores, convenience stores and restaurants throughout North America, and now in many parts of Europe and Asia. In addition to being sold at Costco, Humm can be found at Target, Walmart, Safeway and Whole Foods locations in all 50 states. Headquartered in Bend, Oregon, Humm created the world’s first Kombucha tap room in 2013 and welcomes visitors to grab a glass severn days a week. Visit Humm online at http://www.hummkombucha.com

MEDIA CONTACT:
Kelsey Cycan
Kelsey@harmonica.co Reported by PRWeb 5 hours ago.

↧

Macron and Pope talk poverty, migration and Europe in long meeting

June 26, 2018, 8:07 am

≫ Next: UPDATE -- Relievant Announces Completion of $58M Series E Financing to Support US Commercialization

≪ Previous: Humm Kombucha Launches Its First-Ever, Three-Flavor Variety Pack in Costco

VATICAN CITY (Reuters) - French President Emmanuel Macron, accused at home of straining France's secular foundations by seeking to mend ties with the Catholic Church, discussed Europe, migration and poverty in an unusually long meeting with Pope Francis on Tuesday. Reported by Reuters India 4 hours ago.

↧

UPDATE -- Relievant Announces Completion of $58M Series E Financing to Support US Commercialization

June 26, 2018, 7:46 am

≫ Next: Defuse this explosive migration summit with a strategic EU study

≪ Previous: Macron and Pope talk poverty, migration and Europe in long meeting

*Company to open corporate headquarters in Minneapolis, MN*

MINNEAPOLIS, June 26, 2018 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately-held medical device company developing minimally-invasive solutions for chronic low back pain (CLBP), announced today the completion of a $58 million equity financing. The round was led by Endeavour Vision and included participation from new investor RK Mellon, as well as existing investors New Enterprise Associates, Canaan Ventures, Morgenthaler, and Emergent Ventures."We are pleased to have the support and confidence of this highly respected group of investors," said Kevin Hykes, President and Chief Executive Officer of Relievant. “These new funds will facilitate the US commercial launch of the Intracept Procedure, providing a new, clinically-proven option to the more than five million indicated patients for whom today’s limited CLBP treatment options have proven ineffective.”

Relievant has developed the Intracept® Procedure, a minimally-invasive and clinically-proven approach for the treatment of CLBP and will use the new capital to commercialize the procedure in the United States. The funds will also support continued enrollment in the INTRACEPT study, the company’s second Level I prospective randomized controlled trial, which is being conducted at 20 sites in the US.

"Endeavour Vision is proud to partner with Relievant to support the launch of this important new therapy,” said Alexander Schmitz, who recently joined the Relievant board representing Endeavour Vision. “The ability to intervene early in the CLBP treatment continuum with the Intracept Procedure has the potential to significantly reduce pain and disability, decrease use of healthcare resources, and positively impact the opioid epidemic.”

The company also announced the opening of its corporate headquarters in Minneapolis, MN; it will maintain its existing R&D and operations facility in Sunnyvale, CA.

*About Chronic Low Back Pain (CLBP)*
Chronic low back pain is a widespread and often severely debilitating condition that is estimated to affect nearly 30 million people in the US, costing nearly $150 billion each year in medical treatment and lost productivity. Patients suffering from CLBP typically initiate treatment with conservative therapies such as activity modification, medications, bracing, physical therapy, manipulation and steroid injections. Existing therapies fail to provide adequate pain relief for approximately 80 percent of CLBP patients.

*About the Intracept Procedure *
Relievant’s Intracept Procedure is a new, proven treatment option for the over five million indicated US patients who suffer from CLBP who have not responded to conservative therapies and who may not be candidates for surgery. The marketing clearance from FDA was supported by ground-breaking anatomic research that identified and demonstrated the role of the basivertebral nerve (BVN) in generating low back pain from the vertebral body endplates. The procedure uses a transpedicular, minimally-invasive approach to reach the BVN near the center of the vertebral body and uses radiofrequency energy to ablate the nerve; once ablated, these nerves no longer transmit pain signals. Spine surgeons and interventional pain specialists perform the Intracept Procedure under image guidance in the outpatient setting, with the entire procedure taking 60-90 minutes. Treated patients report nearly immediate relief of their back pain.

*About Endeavour Vision*
Endeavour Vision is an internationally-recognized investor in healthcare and technology companies. The team, which partners successful investment professionals with world-class industry veterans, has executed more than 75 investments within its focus verticals. Endeavour Vision is currently advising the Endeavour Medtech Growth Fund, a €250-million fund dedicated to helping medical technology companies in Europe and the US accelerate their global growth and market leadership. For more information, visit www.endeavourvision.com.

*About Relievant Medsystems*
Founded in 2006 and with offices in Minneapolis, MN, and Sunnyvale, CA, Relievant Medsystems is a privately held medical device company developing new solutions to improve the quality of life for millions of patients suffering from CLBP.

FDA has cleared Relievant’s Intracept System for the following Indications for Use: The Intracept Intraosseous Nerve Ablation System is intended to be used in conjunction with radiofrequency (RF) generators for the ablation of basivertebral nerves of the L3 through S1 vertebrae for the relief of chronic low back pain of at least 6 months duration that has not responded to at least six months of conservative care, and is also accompanied by either Type 1 or Type 2 Modic changes on an MRI.

As with any surgical procedure, there are risks and considerations associated with the Intracept Procedure. Please visit www.relievant.com for a discussion of the risks, contraindications, warnings, precautions and a summary of the pivotal clinical trial data on the device.

*Contact*
Chris Geyen
Relievant Medsystems
(650) 368-1000
investors@relievant.com Reported by GlobeNewswire 4 hours ago.

↧

Defuse this explosive migration summit with a strategic EU study

June 26, 2018, 7:36 am

≫ Next: Harley Shifting Production to Europe Was 'an Obvious Choice' - Analyst

≪ Previous: UPDATE -- Relievant Announces Completion of $58M Series E Financing to Support US Commercialization

If ever an EU summit seemed doomed, it's this week's immigration showdown. Governments like to imply that the 'migrant crisis' is at an end but in truth, it's just starting, and Europe needs a strategy and a common EU-wide approach, writes Gilles Merritt. Reported by EurActiv 4 hours ago.

↧

Harley Shifting Production to Europe Was 'an Obvious Choice' - Analyst

June 26, 2018, 8:02 am

≫ Next: Sport24.co.za | Nainggolan finalises Inter move from Roma

≪ Previous: Defuse this explosive migration summit with a strategic EU study

Reported by RIA Nov. 4 hours ago.

↧

Sport24.co.za | Nainggolan finalises Inter move from Roma

June 26, 2018, 7:49 am

≫ Next: DEAG Deutsche Entertainment Aktiengesellschaft: Buyback of 49% of DEAG Classics AG with simultaneous sale of the shares in Raymond Gubbay Limited

≪ Previous: Harley Shifting Production to Europe Was 'an Obvious Choice' - Analyst

Belgian midfielder Radja Nainggolan called on Inter Milan to step up to play their part in Europe after his transfer from Serie A rivals Roma. Reported by News24 4 hours ago.

↧

DEAG Deutsche Entertainment Aktiengesellschaft: Buyback of 49% of DEAG Classics AG with simultaneous sale of the shares in Raymond Gubbay Limited

June 26, 2018, 8:13 am

≫ Next: The Brief – Desperately seeking cohesion

≪ Previous: Sport24.co.za | Nainggolan finalises Inter move from Roma

DGAP-News: DEAG Deutsche Entertainment Aktiengesellschaft / Key word(s): Miscellaneous

26.06.2018 / 16:59
The issuer is solely responsible for the content of this announcement.
--------------------

*Corporate News*

*DEAG: Buyback of 49% of DEAG Classics AG with simultaneous sale of the shares in Raymond Gubbay Limited*

*- *First successful transaction as part of the long-term strategy to successively reduce minority interests to increase earnings per share

- Core market in the UK to be further expanded

*Berlin, 26 June 2018* - DEAG Deutsche Entertainment Aktiengesellschaft (DEAG), Berlin, ISIN: DE000A0Z23G6, Ticker: ERMK, listed in the Prime Standard, is reacquiring 49% of DEAG Classics AG from Sony Music Entertainment Germany GmbH and will own 100% of the shares in DEAG Classics AG including the shareholding in The Classical Company AG (Switzerland). As part of the transaction, DEAG Classics AG is selling its shares in the English Raymond Gubbay Limited to Sony Music Entertainment International Limited. The joint projects of Raymond Gubbay Limited and DEAG companies such as Kilimanjaro Live Limited will continue unchanged and the cooperation should be further expanded. DEAG Classics works exclusively with Artists like Anna Netrebko and Yusif Eyvazov but also works with Rolando Villazón, the Berlin Philharmonic Orchestra, Till Brönner, Joja Wendt and The Piano Guys and will benefit 100 % from its success going forward. The transaction represents a first step towards successively reducing minority interests with the aim of increasing the earnings per share attributable to DEAG shareholders. Proceeds are intended to further strengthen DEAG's position in its core market of the UK.

Prof. Peter L.H. Schwenkow, CEO and founder of DEAG, comments: "The transaction enables us to continue to achieve two strategic goals. With the complete acquisition of 100% of the shares of DEAG Classics AG, we will increase earnings per share within the next few years. And with the cash inflow of EUR 10,6 million, we are in a position to accelerate the expansion of our position in the British market. The proceeds will also continue to serve our goal of successively reducing minority interests in order to return to an attractive dividend policy."

*About DEAG*

DEAG Deutsche Entertainment AG (DEAG) is a leading entertainment service company and a provider of Live Entertainment in Europe with subsidiaries in its core markets. DEAG produces and profitably organises a broad range of events and concerts. As a Live Entertainment service company with an integrated business model DEAG has extensive expertise in the organisation, marketing and holding of events, as well as in ticket sales via its own ticketing platform 'MyTicket' for its own and third-party content. The highly scalable business model of MyTicket strengthens DEAG on its way to increasing profitability. DEAG promotes around 4,000 concerts and events a year and currently sells more than 5 million tickets, of which a steadily increasing share is sold via its high-turnover ticketing platform MyTicket.

Founded in Berlin in 1978 and listed since 1998, DEAG's core businesses include Rock/Pop, Classics & Jazz, Family Entertainment and Arts+Exhibitions. The Family Entertainment and Arts+Exhibitions divisions in particular are of great importance to the further development of DEAG's own content. With its strong partner network, DEAG is excellently positioned in the market as an internationally active Live Entertainment service company.

DEAG shares (ISIN: DE000A0Z23G6 | WKN: A0Z23G | ERMK) are listed in the Prime Standard of the Frankfurt Stock Exchange, the quality segment of Deutsche Börse.

*IR contact *

cometis AG
Claudius Krause
Phone: +49-611-20585528
e-mail: deag@cometis.de

--------------------

26.06.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de --------------------

Language: English
Company: DEAG Deutsche Entertainment Aktiengesellschaft
Potsdamer Straße 58
10785 Berlin
Germany
Phone: +49-30-810 75-0
Fax: +49-30-810 75-519
E-mail: deag@cometis.de
Internet: www.deag.de
ISIN: DE000A0Z23G6
WKN: A0Z23G
Listed: Regulated Market in Berlin, Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange; London

End of News DGAP News Service Reported by EQS Group 4 hours ago.

↧

The Brief – Desperately seeking cohesion

June 26, 2018, 8:02 am

≫ Next: Optii Solutions Targets $4 Million in Expansion Funding to Optimize Hotel Housekeeping

≪ Previous: DEAG Deutsche Entertainment Aktiengesellschaft: Buyback of 49% of DEAG Classics AG with simultaneous sale of the shares in Raymond Gubbay Limited

In a non-legislative resolution, MEPs urged EU countries on Monday (25 June) to make sure that providing humanitarian help to migrants is not treated as a crime. The mere fact that they felt obliged to do so speaks volumes about where Europe is today. Reported by EurActiv 4 hours ago.

↧

Optii Solutions Targets $4 Million in Expansion Funding to Optimize Hotel Housekeeping

June 26, 2018, 8:03 am

≫ Next: Double the pampering for skin twice as radiant, with the new no-mess 2 in 1 MASK + SCRUB Exfoliating Capsules from BodyBlendz

≪ Previous: The Brief – Desperately seeking cohesion

In a round led by Thayer Ventures, Kinetic Ventures and NextGen Ventures Partners, the intelligent housekeeping platform will expand operations in the U.S.

AUSTIN, Texas (PRWEB) June 26, 2018

Optii Solutions, whose innovative housekeeping optimization platform helps hotels achieve efficiencies and cost savings while transforming the role of the housekeeper on property, announced today an approximate $4 million new round of funding led by Thayer Ventures, Kinetic Ventures and NextGen Venture Partners. HOF Capital and Select Venture Partners, which are existing investors, also participated in the round.

Optii Solutions plans to use the new capital to further expand its U.S. operations, expand sales and marketing activities, build out the company’s product portfolio, and expand customer support functions. Optii Solutions has grown rapidly over the past several years, finding success in hotels worldwide with its improved approach to optimizing housekeeping functions. The Optii platform is currently in place at more than 24,000 hotel rooms globally, with significant room for growth in the dense U.S. hotel market.

“We’re thrilled to partner with Optii Solutions at a pivotal time for the hospitality industry, particularly as they enhance their offerings with technology solutions,” said Jeff Jackson, Managing Director of Thayer Ventures. “Nothing is more on the mind of owners and brands than the future of the industry’s labor force, including housekeeping. Optii Solutions is revolutionizing how hotels manage their housekeeping operations, achieving efficiencies in operations and transforming the role of the housekeeper at the same time. We’re looking forward to further enhancing the company’s growth with financial, operational and business development support.”

Integrating seamlessly with hotels’ operational software programs, Optii Solutions enables hotels to optimize their housekeeping management, achieving measurable improvements while significantly reducing operational costs. Using a patented optimization engine, Optii is able to accurately create real-time workforce deployment schedules capable of reducing direct labor costs by eight to 18%.

“Optii Solutions provides intelligent housekeeping management technology that helps hotels around the world increase productivity, decrease labor costs and improve guest experiences,” says Ray Pawlikowski, Chief Executive Officer of Optii Solutions. “We’re eager to begin helping even more hotels across the nation revolutionize their housekeeping operations with this new round of funding and support from our partners.”

About Optii Solutions
Optii Solutions provides cloud-based software for hotels focused exclusively on automating and optimizing hospitality housekeeping and maintenance functions for realized efficiency. Optii Solutions increases staff productivity by 10-20%, reduces staff turnover by 40%, and produces a 80% reduction in queues. Clients include some of the largest hospitality brands, including Las Vegas Sands, Galaxy Entertainment Group, Intercontinental Hotel Group, and Sodexo. Headquartered in Austin, TX, USA, Optii Solutions has offices in Australia, Hong Kong and Europe. Learn more at http://www.optiisolutions.com.

About Thayer Ventures
Based in San Francisco, Thayer Ventures (Thayer) invests in early-stage technology companies that focus on the travel, hospitality and transportation industries. Thayer’s objective is to provide portfolio companies with unequaled counsel, strategic insights and industry connections that drive significant revenue and enable sustainable growth.

About Kinetic Ventures
Kinetic Ventures is a leading venture capital investor in high growth, industry defining companies. For over three decades, they have partnered with outstanding entrepreneurs to build world-class enterprises.

About NextGen Venture Partners
NextGen Venture Partners is an early stage venture capital firm, featuring the most extensive, connected network of venture partners in the industry. NextGen powers founders through a wide network of founders and innovation executives, which brings unprecedented depth and breadth of expertise and connections. Reported by PRWeb 4 hours ago.

↧

Double the pampering for skin twice as radiant, with the new no-mess 2 in 1 MASK + SCRUB Exfoliating Capsules from BodyBlendz

June 26, 2018, 8:03 am

≫ Next: New Semester of September 2018 to Start at Incheon Global Campus (IGC), the Best Global Education Hub in Northeast Asia

≪ Previous: Optii Solutions Targets $4 Million in Expansion Funding to Optimize Hotel Housekeeping

One part exfoliating coffee scrub and one part detoxifying white clay, topped with exquisite blend of oils, Shea butter and vanilla equals a gloriously healthy, beautiful skin - all conveniently packed in a handy capsule. Perfect for quick pick-me-ups at home or while traveling!

Melbourne, Victoria, Australia (PRWEB) June 26, 2018

Introducing, the world’s first scrub and mask capsules from BodyBlendz

BodyBlendz pampering sessions are a delight to its countless devout users. Luxuriating in BodyBlendz products has always been a joyous head-to-toe experience they revel in prolonging. However, in today’s busy schedule, sometimes there’s not always enough time to indulge in these pleasures.

BodyBlendz understands this and it is for this reason that BodyBlendz designed the new 2 in 1 Mask + Scrub Exfoliating Capsules. Both a gently polishing scrub and a brightening mask, the 2 in 1 Mask + Scrub Exfoliating Capsules, will deliver beautiful glowing and touchable skin in half the time.

Available in 8 capsule packages. The capsules can easily be stacked in the toiletry cabinet or tossed into the travel bag. Each capsule is measured with enough goodness for single use. That means no more guessing if the right amount is used.

BodyBlendz 2 in 1 Mask + Scrub Exfoliating Capsules: What it does.·     Buffs, polishes and improves the skin’s texture
·     Removes dead, dry skin cells, revealing fresh new skin
·     Restores the skin’s hydration
·     Detoxifies the skin and eliminates impurities
·     Enriches the skin with moisturising ingredients
·     Easy and convenient to use and carry
·     Is kind to the earth. Our products are all natural, vegan and cruelty free.

BodyBlendz 2 in 1 Mask + Scrub Exfoliating Capsules: What’s in it?

BodyBlendz 2 in 1 Mask + Scrub Exfoliating Capsules is packed with all-natural goodness from a mix of organic essential oils that contains antioxidant, anti-inflammatory, antiseptic, and anti-aging properties that helps give healthy, smooth skin.

Key natural ingredients in this facial exfoliating pods are ground Arabica coffee, Australian white clay, shea butter, jojoba oil, aloe vera and Vitamin E.

·     Ground Arabica Coffee are rich in antioxidants that not only slough off dead skin cells but also combat skin diseases and aging as well as reduces visibility of acne, cellulite, stretch marks and psoriasis.
·     Australian White Clay draws out bacteria, dirt and other toxins that effectively treats skin problems like acne and clogged pores.
·     Shea Butter reduces inflammation, soothes and moisturizes skin.
·     Jojoba Oil is packed with essential nutrients that repair, hydrate and provide natural oils that help slow the aging process.
·     Aloe Vera accelerates skin healing, soothes rashes and sunburn, anti-inflammatory, and lightens blemishes.
·     Vitamin E, a powerful antioxidant, protects skin from sun damage, hydrates and nourishes the skin as well as prevents the appearance of fine lines and wrinkles.

As with all BodyBlendz products, the BodyBlendz 2 in 1 Mask + Scrub Exfoliating Capsules is rich with healthy, organic ingredients, but free from SLS, SLES and other harmful irritants; and is 100% cruelty free and vegan!

Use 2-3 times weekly to see beautiful, steady results.

Available in 10ml capsules, packs of 8.

Creamy Vanilla Coffee hard at work!

Simply peel back the cover, massage in an upward motion on damp or dry skin and leave for five to ten minutes. Relax and let the hard-working 2 in 1 formula do the job. Rinse to uncover refreshed, soothed skin.

BodyBlendz 2 in 1 Mask + Scrub Exfoliating Capsules is infused with the exotic scent of vanilla, coffee butter and shea butter, this nourishing formulation contains skin-loving ingredients that deeply hydrate, while bestowing a beautiful aroma. Suitable for all skin types.

About BodyBlendz

BodyBlendz was created in Australia in March 2014 out of a passion to create products that not only evoke a complete sensory delight, but also burst with Mother Nature’s super ingredients, to ensure real results while being kind to the planet. Fast forward just a few short years and BodyBlendz has reached cult status in the U.S, Europe and Brazil with their coffee-based scrubs that are free of any harmful chemicals and full of only natural ingredients. The entire process of creating BodyBlendz products is done in Australia, from concept, to manufacturing to sourcing our super ingredients. Reported by PRWeb 4 hours ago.

↧

New Semester of September 2018 to Start at Incheon Global Campus (IGC), the Best Global Education Hub in Northeast Asia

June 26, 2018, 8:04 am

≫ Next: New Semester of September 2018 to Start at Incheon Global Campus (IGC), Best Global Education Hub in Northeast Asia

≪ Previous: Double the pampering for skin twice as radiant, with the new no-mess 2 in 1 MASK + SCRUB Exfoliating Capsules from BodyBlendz

SONGDO INTERNATIONAL BUSINESS DISTRICT, South Korea, June 26, 2018 /PRNewswire/ -- Incheon Global Campus (IGC) located in Songdo has the vision of creating the 'Best Global Education Hub in Northeast Asia' as Korea's first shared campus of foreign prestigious universities. It is a national project by the Ministry of Strategy and Finance, the Ministry of Trade, Industry and Energy, the Ministry of Education, and Incheon City Government. The goal is to attract 10 foreign universities ranked among the top 100 in the world rankings. The campus is being built with ultra-modern facilities that allow about 10,000 students to study.

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8353751-incheon-global-campus-igc-korea-new-semester/

The first university to be entered in this Korea's first joint campus was the State University of New York in March 2012, and George Mason University in March 2014, Ghent University and the University of Utah in September 2014, and the FIT (Fashion Institute of Technology) of the State University of New York opened in September last year.

The students are not only Korean but also students from various countries all over the world. The campus has about 2,000 students from more than 40 countries. From January of last year, IGC has produced graduates while the IGC college's high-level educational curriculum has been continuing to be visible. These first graduates were recognized for their competitiveness by being successful in entering domestic and foreign graduate schools, law schools, companies such as LG Electronics, Facebook Singapore, a semiconductor company and KPMG, a multinational corporation, and so on.

The foreign universities of IGC confer the same degree as the home campus when the students graduate from the extended campus, and they will have the opportunity to study at home campuses in the US and Europe. IGC's strengths are its internship experience and various club activities. Universities voluntarily conduct festivals and events. Sports tournaments jointly organized by universities, as well as joint festivals held in October, are only possible on this shared campus.

The focus of IGC Foundation, is to raise the satisfaction level of the campus community, which is a family, as a priority strategy. "IGC will maximize synergy by linking with international organizations and corporations located in Songdo International City, and strive to create an environment where each university can develop and financially become independent. We will do our best to become the 'world's best global education hub' exceeding the vision 'Northeast Asia's best global education hub'," said Kihyung Kim, CEO of IGC Foundation.

*- Admission Information*

· Stony Brook, the State University of New York is recruiting new students for Spring 2019, following the fall semester of 2018. The Open House program runs every Thursday.
*(Inquiries: Stony Brook, +82-32-626-1114 / FIT, +82-32-626-1162, **http://sunykorea.ac.kr/**)*
· Admission consultation for George Mason University in Korea is also available at Seoul office in Gangnam, Seoul. The application for the fall semester 2018 will be accepted until July 31.
*(Inquiries: +82-32-626-5021, **askmk@gmu.edu**, **https://masonkorea.gmu.edu/**)*
· Ghent University Global Campus 2018 Fall semester application will be accepted until July 20.
*(Inquiries: +82-32-626-4004, **https://www.ugent.be/globalcampus/en**)*
· The University of Utah Asia Campus 2018 Fall semester application will be accepted until June 30.
*(Inquiries: +82-32-626-6000, **https://asiacampus.utah.edu/**)* Reported by PR Newswire Asia 4 hours ago.

↧

New Semester of September 2018 to Start at Incheon Global Campus (IGC), Best Global Education Hub in Northeast Asia

June 26, 2018, 8:04 am

≫ Next: Beijing’s bay area plan for southern China is the focus as state leader Han Zheng meets Hong Kong’s Carrie Lam

≪ Previous: New Semester of September 2018 to Start at Incheon Global Campus (IGC), the Best Global Education Hub in Northeast Asia

New Semester of September 2018 to Start at Incheon Global Campus (IGC), Best Global Education Hub in Northeast Asia

SONGDO INTERNATIONAL BUSINESS DISTRICT, South Korea, June 26, 2018 /PRNewswire/ -- Incheon Global Campus (IGC) located in Songdo has the vision of creating the "Best Global Education Hub in Northeast Asia" as Korea's first shared campus of foreign prestigious universities. It is a national project by the Ministry of Strategy and Finance, the Ministry of Trade, Industry and Energy, the Ministry of Education, and Incheon City Government. The goal is to attract 10 foreign universities ranked among the top 100 in the world rankings. The campus is being built with ultra-modern facilities that allow about 10,000 students to study.

To view the Multimedia News Release, please click:
https://www.multivu.com/players/English/8353751-incheon-global-campus-igc-korea-new-semester/

Admission Info of SUNY Korea

Admission Info of George Mason Univ. of Korea

Admission Info of Ghent University Global Campus

Admission Info of The University of Utah Asia Campus

The first university to be entered in this Korea's first joint campus was the State University of New York in March 2012, and George Mason University in March 2014, Ghent University and the University of Utah in September 2014, and the FIT (Fashion Institute of Technology) of the State University of New York opened in September last year.

The students are not only Korean but also students from various countries all over the world. The campus has about 2,000 students from more than 40 countries. From January of last year, IGC has produced graduates while the IGC college's high-level educational curriculum has been continuing to be visible. These first graduates were recognized for their competitiveness by being successful in entering domestic and foreign graduate schools, law schools, companies such as LG Electronics, Facebook Singapore, a semiconductor company and KPMG, a multinational corporation, and so on.

The foreign universities of IGC confer the same degree as the home campus when the students graduate from the extended campus, and they will have the opportunity to study at home campuses in the US and Europe. IGC's strengths are its internship experience and various club activities. Universities voluntarily conduct festivals and events. Sports tournaments jointly organized by universities, as well as joint festivals held in October, are only possible on this shared campus.

The focus of IGC Foundation, is to raise the satisfaction level of the campus community, which is a family, as a priority strategy. "IGC will maximize synergy by linking with international organizations and corporations located in Songdo International City, and strive to create an environment where each university can develop and financially become independent. We will do our best to become the 'world's best global education hub' exceeding the vision 'Northeast Asia's best global education hub'," said Kihyung Kim, CEO of IGC Foundation.

- Admission Information

· Stony Brook, the State University of New York is recruiting new students for Spring 2019, following the fall semester of 2018. The Open House program runs every Thursday. (Inquiries: Stony Brook, +82-32-626-1114 / FIT, +82-32-626-1162, http://sunykorea.ac.kr/)
· Admission consultation for George Mason University in Korea is also available at Seoul office in Gangnam, Seoul. The application for the fall semester 2018 will be accepted until July 31. (Inquiries: +82-32-626-5021, askmk@gmu.edu, https://masonkorea.gmu.edu/)
· Ghent University Global Campus 2018 Fall semester application will be accepted until July 20. (Inquiries: +82-32-626-4004, https://www.ugent.be/globalcampus/en)
· The University of Utah Asia Campus 2018 Fall semester application will be accepted until June 30. (Inquiries: +82-32-626-6000, https://asiacampus.utah.edu/)

Media Contact:

Dohee Kwon
Office: +82-32-626-0555
Email: dhkwon@igc.or.kr

Video - https://cdn4.prnasia.com/002071/mnr/201806/igc/video.mp4
Photo - https://photos.prnasia.com/prnh/20180621/2167104-1-a
Photo - https://photos.prnasia.com/prnh/20180621/2167104-1-b
Photo - https://photos.prnasia.com/prnh/20180621/2167104-1-c
Photo - https://photos.prnasia.com/prnh/20180621/2167104-1-d Reported by PR Newswire Asia 4 hours ago.

↧

Beijing’s bay area plan for southern China is the focus as state leader Han Zheng meets Hong Kong’s Carrie Lam

June 26, 2018, 8:09 am

≫ Next: Vitro Bio-Pharma 2nd Quarter Ended April 30th 2018 Financial Results of Operations

≪ Previous: New Semester of September 2018 to Start at Incheon Global Campus (IGC), Best Global Education Hub in Northeast Asia

Hong Kong leader Carrie Lam Cheng Yuet-ngor on Tuesday had her first formal meeting with Chinese Vice-premier Han Zheng since the state leader was appointed to take charge of the city’s affairs. The event appeared to be hastily arranged as Lam made a surprise detour through Beijing on her way back to Hong Kong from a visit to Europe, with the stop in the capital previously unannounced. It was also Han’s first meeting with Lam since he was promoted to vice-premier in March, a... Reported by S.China Morning Post 4 hours ago.

↧

Vitro Bio-Pharma 2nd Quarter Ended April 30th 2018 Financial Results of Operations

June 26, 2018, 8:04 am

≫ Next: Tredence Named in Gartner Market Guide for Data and Analytics Service Providers, 2018

≪ Previous: Beijing’s bay area plan for southern China is the focus as state leader Han Zheng meets Hong Kong’s Carrie Lam

Vitro Bio-Pharma 2nd Quarter Ended April 30th 2018 Financial Results of Operations

*GOLDEN, CO / ACCESSWIRE / June 26, 2018 /* Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro BioPharma, announced its 2^nd quarter ended April 30^th 2018 financial results of operations.

*Vitro Diagnostics Inc. (''Vitro'') is pleased to announce a record 2^nd quarter in Stem Cell Revenues. Vitro recorded 2^nd quarter revenues of $125,886 vs $56,633 an increase of 222% over the same comparative quarter last year.* In addition, Stem Cell therapies accounted for 53% of the revenues up from only 8% of the revenues in the prior comparative quarter last year. Current quarter stem cell revenues from our advanced stem cell therapies with our offshore partners was $66,537 for the 2^nd quarter ended April 30^th, 2018 vs $4,594 for the 2^nd quarter ended April 30^th, 2017.

*The company's gross profit margins improved to 75% up from 50% in the comparative prior year's quarter.* Gross margin improvement is in line with the strategic direction of the company to expand the market in its offshore Stem Cell therapies. The company's clean-room lab expansion last year and increase in its batch Stem Cell manufacturing and production capacity to 2 Billion cells per harvest, using its patent-pending cell line, has increased efficiencies and lowered the cost per harvest.

Overall operating expenses increased in the quarter to $121,080 from $106,068 in the prior year's comparative quarter. The increase in expenses reflects the addition of additional team resources as the Company expands its capability to service its strategic direction of offshore Stem Cell sales. The company has added internal operations staff in the stem cell lab; outside consultants supporting its efforts towards CLIA and ISO certification as well as the addition of internal accounting, finance and administrative support staff compared to the prior year.

*The company raised financing and reduced debts for its expansion from the issuance of 3 year convertible notes; due December 31^st 2021, bearing interest at 10% per annum; convertible into the common stock of the company at $0.05 cents per share. During the quarter $137,500 of the notes were converted to 2,700,000 shares of common stock. As at April 30^th, 2018 there were $238,750 of outstanding notes and deferred interest. Subsequent to April 30^th the company has issued an additional $285,000 of notes from fund raising activities.*

*The company's CEO converted $1,003,119 of his debts to 20,062,378 shares of common stock. As at April 30^th the company's founder, C.E.O. and Chairman of the Board owned approximately 57% of the company's common stock. The company entered into 5 year employment agreements with its C.E.O., C.O.O. and C.F.O. establishing an experienced executive team committed to the company's aggressive growth plans*

*During the quarter the company achieved and pursed the following company objectives;*

· *Accelerated the Company's Marketing Program*

We had previously worked with a New Zealand patient diagnosed with a type of Parkinson's disease called Multiple System Atrophy (MSA), a fatal condition without effective treatment. She had previously received our stem cell activation therapy, *NutraVivo™* that helped to stabilize her but without changing her symptoms. She has now received 3 transplants of stem cells manufactured by Vitro Biopharma and had subsequent reversal of some neurological symptoms.

www.stuff.co.nz/national/103061387/experimental-stem-cell-treatment-shows-results-for-waikato-woman-with-msa-cerebella

· This trial has been expanded to include 6 patients with neurodegenerative diseases, including MSA and ALS.
· Regulatory approval was obtained through a New Zealand statute comparable to the ''Right to Try'' in the US.
· Preliminary results continue to show clinical safety of the procedure while showing reversals of some neurological symptoms.
· During the quarter our Cayman Island partner launched its new medical tourism web site and added a marketing manager. www.dvcstem.com

· *Expanded opportunities for stem cell therapies in the US:*

We continued the initial commercialization of *NutraVivo™*, our patent-pending nutraceutical formulation for treatment of *Concussion/TBI* by establishing initial testing and publication of evidence for stem cell activation.

https://vitrobiopharma.com/stem-cell-activation-by-nutravivo-dietary-supplements/

https://vitrobiopharma.com/wp-content/uploads/2018/04/Stem-cell-activation-by-natural-substances-white-paper.pdf

· Began Social Media postings

https://www.instagram.com/vitro.biopharma/

· Hired an IT firm for complete integration of marketing, social media and web presence.

· *Research and Development:*

· Developing methods for topical stem cell delivery and enhanced penetration of the blood-brain barrier.
· Completed comparative study of MSCs derived from adipose, placental, bone marrow and umbilical cord tissue: Results show bio-similarity with superior potency & differentiation capacity of our patent-pending MSCs derived from umbilical cord.

Dr. Jim Musick, CEO/CSO said, ''We are pleased to see continued revenue growth due to the expansion of our prior R&D operations to include stem cell therapies initially targeting off-shore clinics while pursing US markets as well. Our existing operations in Australia, Grand Cayman Islands and Eastern Europe continue to expand. During our second quarter, we added supply of stem cell therapies to a clinical partner in New Zealand. Regulatory authority was obtained through a statutory provision like the ''right to try'' in the US that was recently approved by the US federal government. The initial results are promising, and our protocol includes longer term follow-up with more quantitative diagnostics to compare pre-and post-treatment results. We plan to continue these studies and expand to broader clinical trials of neurological disease & conditions. Operations in the US are initially focused on stem cell activation therapies for concussion/TBI using our patent-pending *NutraVivo™* nutraceutical formulation that has been shown to activate neural stem cells. Thus, our overall strategy provides numerous revenue streams from off-shore operations while developing stem therapies targeting select US markets positioning the Company for substantial revenue growth and increased shareholder value.''

In summary, Vitro Biopharma is advancing as a key player in regenerative medicine with 10 years' experience in the development and commercialization of stem cell cell products for research, recognized by a Best in Practice Technology Innovation Leadership award for Stem Cell Tools and Technology and a growing track record of successful translation to therapy. We plan to leverage our proprietary technology platform to the establishment of international Stem Cell Centers of Excellence and regulatory approvals in the US.

Sincerely yours,

James R. Musick, PhD.
CEO & CSO
www.vitrobiopharma.com

*Forward-Looking Statement*

Statements herein regarding financial performance have not yet been reported to the SEC nor reviewed by the Company's auditors. Certain statements contained herein and subsequent statements made by and on behalf of the Company, whether oral or written may contain ''forward-looking statements''. Such forward looking statements are identified by words such as ''intends,'' ''anticipates,'' ''believes,'' ''expects'' and ''hopes'' and include, without limitation, statements regarding the Company's plan of business operations, product research and development activities, potential contractual arrangements, receipt of working capital, anticipated revenues and related expenditures. Factors that could cause actual results to differ materially include, among others, acceptability of the Company's products in the market place, general economic conditions, receipt of additional working capital, the overall state of the biotechnology industry and other factors set forth in the Company's filings with the Securities and Exchange Commission. Most of these factors are outside the control of the Company. Investors are cautioned not to put undue reliance on forward-looking statements. Except as otherwise required by applicable securities statutes or regulations, the Company disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.

*CONTACT: *

Dr. James Musick
Chief Executive Officer
Vitro BioPharma
(303) 999-2130 Ext. 3
E-mail: jim@vitrobiopharma.com
www.vitrobiopharma.com

*The company provides its financial information for investor purposes only, the results published are not audited or necessarily SEC or GAAP compliant.*

*The company provides its financial information for investor purposes only, the results published are not audited or necessarily SEC or GAAP compliant.*

*The company provides its financial information for investor purposes only, the results published are not audited or necessarily SEC or GAAP compliant.*

*SOURCE: *Vitro Diagnostics, Inc. Reported by Accesswire 4 hours ago.

↧

Tredence Named in Gartner Market Guide for Data and Analytics Service Providers, 2018

June 26, 2018, 8:37 am

≫ Next: Emmanuel Macron and Pope talk poverty, migration and Europe in unusually long meeting

≪ Previous: Vitro Bio-Pharma 2nd Quarter Ended April 30th 2018 Financial Results of Operations

Report lists external service providers that can accelerate the success of data and analytics programs

SAN JOSE, Calif., June 26, 2018 (GLOBE NEWSWIRE) -- Tredence, the first analytics services company focused on the last mile of analytics adoption, announced today that it has been included in the Gartner Market Guide for Data and Analytics Service Providers, 2018, which lists external service providers that can accelerate the success of data and analytics programs. Vendors are placed on the list based on their market visibility, as well as mind share among Gartner clients and analysts, including client inquiries and research, presence at industry events, and participation in a recent Gartner analyst briefing.“We are thrilled to be included in Gartner’s Market Guide for Data and Analytics Services Providers, a key resource for companies looking for external analytics partners,” said Tredence co-founder and CEO Shub Bhowmick. “Tredence has a proven track record helping large enterprises solve challenging business problems using data and technology – more than one client has said we are their secret analytics weapon.”

Headquartered in San Jose, Calif., Tredence partners with clients across verticals, with deep experience in the retail, CPG, industrial, travel and hospitality, food and beverage, telecom, pharmaceutical and financial services spaces.

There are four broad steps to enabling last-mile analytics adoption within enterprises: data analysis, generating insights, making recommendations, and translating those recommendations into action for the front lines leading to sustainable business impact. While other analytics services firms focus only on the first three steps, Tredence covers all four. The last step is crucial toward operationalizing analytics.

*About Tredence *
Tredence focuses on last mile delivery of insights into actions by uniting its strengths in business analytics, data science and software engineering. The largest companies across industries are engaging with Tredence and deploying its prediction and optimization solutions at scale – empowering end users to improve decision making. Tredence is helping its clients deliver on the artificial intelligence imperative, in a practical and demystified way. Headquartered in the San Francisco Bay Area, the company serves clients in US, Canada, Europe, Australia and SE Asia. Tredence is doubling in size year over year and has grown exclusively through client referrals. Learn more at www.tredence.com or follow @TredenceInc.

Source: Gartner, Market Guide for Data and Analytics Service Providers, 18 June 2018
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Media Contact:
Michelle Faulkner
Big Swing Communications
+1 617-510-6998
michelle@big-swing.com Reported by GlobeNewswire 3 hours ago.

↧

Emmanuel Macron and Pope talk poverty, migration and Europe in unusually long meeting

June 26, 2018, 8:44 am

≫ Next: Inaugural TripAdvisor Awards reveal the UK's highest rated experiences

≪ Previous: Tredence Named in Gartner Market Guide for Data and Analytics Service Providers, 2018

Reported by Telegraph.co.uk 3 hours ago.

↧

Inaugural TripAdvisor Awards reveal the UK's highest rated experiences

June 26, 2018, 8:49 am

≫ Next: Tulip suspends output at Scottish plant amid CO2 shortage

≪ Previous: Emmanuel Macron and Pope talk poverty, migration and Europe in unusually long meeting

Inaugural TripAdvisor Awards reveal the UK's highest rated experiences

Today TripAdvisor announced the winners of its first-ever Travellers' Choice awards for Experiences, with a London to Stonehenge day trip being voted the best experience on offer in the UK.

The awards, which recognise 345 experiences, tours, and activities globally, uses an algorithm that looks at business reviews, opinions, and popularity over the last year to determine the winners.

Although a distinctly Italian experience - a cooking class in a Tuscan farmhouse followed by a local market tour - won out, day trips from London to Stonehenge and Glasgow to Loch Ness both appeared in the top 25 globally and were the top rated experiences in the UK.

*Read more*: These have been named the top cities for business travel in Europe

A London Rock Music Tour, which delves deep into the musical history of the capital, and a Warner Bros. Studio Tour about the making of Harry Potter are third and fourth on the UK list respectively.

Rounding out the UK's top five is another day trip to Loch Ness, this time from Edinburgh, while the rest consist of hop-on hop-off tours, visits to the Tower of London, and a day trip in Belfast.

TripAdvisor spokesperson James Kay said: "Travel is all about new experiences and these awards, decided by reviews and ratings from the TripAdvisor community, showcase some of the best things to do around the world for every type of traveller."

*Top 10 experiences in the UK*

1. Inner Circle Access of Stonehenge including Bath and Lacock Day Tour from London - £139
2. Loch Ness, Glencoe, and the Highlands Small Group Day Trip from Glasgow - £44
3. London Rock Music Tour - £35
4. Warner Bros. Studio Tour London: The Making of Harry Potter - £77
5. Loch Ness, Glencoe and the Highlands Small Group Day Trip from Edinburgh - £46
6. Tower of London Entrance Ticket including Crown Jewels and Beefeater Tour - £26

7. The Original London Sightseeing Tour: Hop-on Hop-off - £32
8. City Sightseeing Edinburgh Hop-on Hop-off Tour - £15
9. Tower of London, Changing the Guard, Thames Cruise with Harrods Cream Tea or London Eye Upgrade - £99
10. Giant's Causeway Day Trip from Belfast - £20

*Top 10 experiences in the world*

1. Cooking Class and Lunch at a Tuscan Farmhouse with Local Market Tour - Florence, Italy
2. Berlin Bike Tour - Berlin, Germany
3. New York in One Day Guided Sightseeing Tour - NYC, NY
4. Sydney BridgeClimb - Sydney, Australia
5. Vatican VIP Experience: Exclusive Breakfast at the Vatican with Early Access to Vatican Museum and Sistine Chapel - Rome, Italy
6. New Orleans Cooking Class - New Orleans, LA
7. Rotorua Maori Hangi Dinner and Performance - Rotorua, New Zealand
8. Best of Niagra Falls Tour from Niagra Falls, Ontario - Niagra Falls, Canada
9. Vancouver to Victoria and Butchart Gardens Tour by Bus - Vancouver, Canada
10. Wild Wicklow Tour including Glendalough from Dublin - Dublin, Ireland

Reported by City A.M. 3 hours ago.

↧

Tulip suspends output at Scottish plant amid CO2 shortage

June 26, 2018, 8:52 am

≫ Next: U.S. tariffs funnel Asian steel to Canada's oil industry

≪ Previous: Inaugural TripAdvisor Awards reveal the UK's highest rated experiences

Danish Crown UK subsidiary Tulip has suspended production at an abattoir in Scotland it runs in conjunction with Scottish Pig Producers as Europe's carbon dioxide gas shortage starts to bite. Reported by Just-Food 3 hours ago.

↧

U.S. tariffs funnel Asian steel to Canada's oil industry

June 26, 2018, 11:12 am

≫ Next: Netherlands joins Europe move to ban Islam face veil

≪ Previous: Tulip suspends output at Scottish plant amid CO2 shortage

WINNIPEG, Manitoba/TORONTO (Reuters) - Steel pipes and tubes used in drilling and transporting crude oil flooded into Canada this spring, a Reuters analysis shows, as U.S. President Donald Trump's steel tariffs forced producers from Asia to Europe to seek new markets. Reported by Reuters 45 minutes ago.

↧